Ads
-
Related paper
- The State of the System of Matrix Metalloproteinases and of their Tissue Inhibitors in Patients with Metabolic Syndrome
- Green and brown propolis as antioxidant, antimicrobial and inhibitors of matrix metalloproteinases in endodontics
- Effects on Metabolic Parameters of Addition of SGLT‐2 Inhibitors on Patients with Type2 Diabetes Inadequately Controlled with DPP‐IV Inhibitors and Metformin
- CORRELATION OF THE LEVELS OF THYROID HORMONES WITH VARIOUS COMPONENTS OF METABOLIC SYNDROME IN PATIENTS DIAGNOSED WITH METABOLIC SYNDROME
- THE IMPACT OF OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME ON THE LEVELS OF TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE-1 AND HYPOXIA-INDUCIBLE FACTOR-1Α IN ATRIAL FIBRILLATION PATIENTS
- EFFECT OF METABOLIC PARAMETERS AND HS - CRP LEVELS ON CARDIAC AUTONOMIC FUNCTION IN PATIENTS WITH METABOLIC SYNDROME
- THE STATE OF ENDOTHELIAL PROCESSES IN PATIENTS WITH CHRONIC HEART FAILURE UNDER TREATMENT OF INHIBITORS OF RENIN-ANGIOTENSIN SYSTEM
- THE ROLE OF MATRIX METALLOPROTEINASES IN PULMONARY DISEASES DEVELOPMENT
- THE SIGNIFICANCE OF MATRIX METALLOPROTEINASES IN PATHOGENESIS OF GENITAL ENDOMETRIOSIS
- Recent Advances in Role of Matrix metalloproteinases in Some Dental Diseases